Lyphe is proud to announce the launch of its new low-cost medical cannabis line, Noidecs Vital, designed to address affordability issues for medical patients. Recognising the...
The first domestically grown medical cannabis is now available to patients in the UK.
Scientists at 113 Botanicals and the University of Sussex are developing new formulations for cannabis-based medicines.
The CRDG will set out the country’s first comprehensive strategy for cannabinoid research and development.
Avata Biosciences is developing solid dose cannabinoid medicines for epilepsy and other neurological disorders.
The UK is the primary driver of new growth in Europe’s medical cannabis market, with sales of medical cannabis greater than expected due to ‘unusually high’...
The UK’s Food Standards Agency (FSA) has issued the first two ‘positive safety assessments’ for CBD (cannabidiol) products as part of its years-long novel foods authorisation...
A crowdfunder aims to raise £20,000 to undertake public relations and promotional activity around the existence and benefits of prescription cannabis.
The move will enable individuals with conditions such as anxiety, ADHD or PTSD to access treatment through Treat It clinic.
Cristelle Santos, consultant toxicologist at Broughton Group, shares her experiences as a toxicologist in the CBD sector.
